Scientists from Northwestern Medicine and the University of Chicago identified elevated levels of a regulatory protein called beta-catenin in the T-cells of patients with colon cancer.
A group of physician-scientists at Northwestern Medicine has shown that 10 mL of local anesthetic has the same effect as the commonly used 30 mL to provide sciatic block in patients undergoing knee replacement.
Published in PLOS ONE, the findings by a group of neurosurgeons could change the manner in which a fairly common lumbar procedure is performed in the future.
Alumnus Julian D’Achille’s global health experiences in South Africa and Nicaragua led him to seek out international health opportunities during his residency and master’s degree in public health.
Developed by Gregory Dumanian, MD, and Todd A Kuiken, MD, PhD, targeted muscle reinnervation enables an amputee to control motorized prosthetic devices and regain sensory feedback. New research also shows that it reduces neuroma pain from cut nerve endings.
Dimitri Krainc and Andrew Parsa had only heard of each other before they came to Northwestern Medicine. Now they share a vision as new leaders for the academic and clinical missions in neurology and neurosurgery.
Northwestern University researchers are the first to design a bioactive nanomaterial that promotes the growth of new cartilage in vivo and without the use of expensive growth factors.